Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models

• Dorothy M. French ,

  Contributed equally to this work with: Dorothy M. French, Benjamin C. Lin

  Affiliation Department of Pathology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Benjamin C. Lin ,

  Contributed equally to this work with: Dorothy M. French, Benjamin C. Lin

  * E-mail: lin.ben@gene.com

  Current address: Oncology Biomarker Development/Pharmacodynamic Biomarkers Oncology, Genentech, Inc., South San Francisco, California, United States of America

  Affiliation Department of Molecular Oncology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Manping Wang,

  Affiliation Department of Molecular Oncology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Camellia Adams,

  Affiliation Department of Antibody Engineering, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Theresa Shek,

  Affiliation Department of Antibody Engineering, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Kathy Hötzel,

  Affiliation Department of Pathology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Brad Bolon,

  Affiliation GEMpath, Inc., Longmont, Colorado, United States of America

  ⨯
• Ronald Ferrando,

  Affiliation Department of Pathology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Craig Blackmore,

  Current address: Public Health Laboratory, San Mateo County, San Mateo, California, United States of America

  Affiliation Department of Molecular Oncology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Kurt Schroeder,

  Affiliation Department of Antibody Engineering, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Luis A. Rodriguez,

  Affiliation Department of Pathology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Maria Hristopoulos,

  Affiliation Department of Cancer Signaling and Translational Oncology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Rayna Venook,

  Affiliation Department of Cancer Signaling and Translational Oncology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Avi Ashkenazi,

  Affiliation Department of Molecular Oncology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯
• Luc R. Desnoyers

  Current address: Oncology Biomarker Development/Pharmacodynamic Biomarkers Oncology, Genentech, Inc., South San Francisco, California, United States of America

  Affiliation Department of Molecular Oncology, Genentech, Inc., South San Francisco, California, United States of America

  ⨯